Antares Pharma OverviewAntares Pharma Operating Income
Operating Income for ATRS.
Quarterly Operating Income
$-2820000.00
↓ 152.31% YoY
As of Mar 31, 2022
Annual Operating Income (TTM)
$19.13M
↓ 6.13% YoY
Trailing 12 months ending Mar 31, 2022
Antares Pharma OverviewOperating Income for ATRS.
As of Mar 31, 2022
Trailing 12 months ending Mar 31, 2022